BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1700771)

  • 1. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1.
    Brandt CR; Salkowski CA
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):113-20. PubMed ID: 1370438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High cytotoxic activity against herpes simplex virus type 1 infected targets found in murine peritoneum.
    Brownridge E; Lopez C
    Nat Immun Cell Growth Regul; 1986; 5(6):294-304. PubMed ID: 2432414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenetic influence of Igh-1 phenotype on experimental herpes simplex virus type-1 corneal infection.
    Opremcak EM; Wells PA; Thompson P; Daigle JA; Rice BA; Millin JA; Foster CS
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):749-54. PubMed ID: 3366566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A; Carrasco L; Fresno M
    J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.
    Habu S; Akamatsu K; Tamaoki N; Okumura K
    J Immunol; 1984 Nov; 133(5):2743-7. PubMed ID: 6207244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice.
    Tamesis RR; Messmer EM; Rice BA; Dutt JE; Foster CS
    Eye (Lond); 1994; 8 ( Pt 3)():298-306. PubMed ID: 7958034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
    Hendricks RL; Sugar J
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV; Schoon RA; Leibson PJ
    J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA; Glorioso JC; Schwartz SA
    J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA; von Wussow P; Lopez C
    J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.